| Primary |
| Product Used For Unknown Indication |
22.3% |
| Nonketotic Hyperglycinaemia |
17.0% |
| Erectile Dysfunction |
16.0% |
| Pulmonary Hypertension |
14.9% |
| Pulmonary Arterial Hypertension |
13.8% |
| Hiv Infection |
3.2% |
| B-cell Lymphoma |
2.1% |
| Sexual Dysfunction |
2.1% |
| Blood Pressure Decreased |
1.1% |
| Cardiac Disorder |
1.1% |
| Cardiac Failure Congestive |
1.1% |
| Chest Pain |
1.1% |
| Hypertension |
1.1% |
| Ill-defined Disorder |
1.1% |
| Phytotherapy |
1.1% |
| Pulmonary Fibrosis |
1.1% |
|
| Pulmonary Oedema |
11.9% |
| Chest Pain |
9.5% |
| Death |
9.5% |
| Syncope |
9.5% |
| Condition Aggravated |
7.1% |
| Malaise |
7.1% |
| Respiratory Failure |
7.1% |
| Headache |
4.8% |
| Treatment Failure |
4.8% |
| Unresponsive To Stimuli |
4.8% |
| Dilatation Atrial |
2.4% |
| Drug Effect Decreased |
2.4% |
| Drug Ineffective |
2.4% |
| Dyspnoea |
2.4% |
| Ear Discomfort |
2.4% |
| Erection Increased |
2.4% |
| Glaucoma |
2.4% |
| Hemiplegia |
2.4% |
| Hyperhidrosis |
2.4% |
| Hyperthyroidism |
2.4% |
|
| Secondary |
| Product Used For Unknown Indication |
46.2% |
| Pulmonary Arterial Hypertension |
16.2% |
| Pulmonary Hypertension |
10.9% |
| Drug Use For Unknown Indication |
8.7% |
| Erectile Dysfunction |
3.0% |
| B-cell Lymphoma |
2.7% |
| General Anaesthesia |
2.7% |
| Pulmonary Fibrosis |
1.6% |
| Suicide Attempt |
1.1% |
| Hypertension |
0.9% |
| Addison's Disease |
0.7% |
| Bipolar Disorder |
0.7% |
| Crest Syndrome |
0.7% |
| Hypertensive Heart Disease |
0.7% |
| Interstitial Lung Disease |
0.7% |
| Wegener's Granulomatosis |
0.7% |
| Blood Pressure |
0.5% |
| Erysipelas |
0.5% |
| Gastrooesophageal Reflux Disease |
0.5% |
| Glomerulonephritis Rapidly Progressive |
0.5% |
|
| Death |
10.4% |
| Completed Suicide |
9.0% |
| White Blood Cell Count Decreased |
9.0% |
| Pulmonary Hypertension |
7.5% |
| Electrocardiogram Qrs Complex Prolonged |
6.0% |
| Pulmonary Fibrosis |
6.0% |
| Rectal Haemorrhage |
6.0% |
| Dyspnoea |
4.5% |
| Hypotension |
4.5% |
| Pyrexia |
4.5% |
| Throat Tightness |
4.5% |
| Vision Blurred |
4.5% |
| Cardiac Arrest |
3.0% |
| Chronic Obstructive Pulmonary Disease |
3.0% |
| Delirium |
3.0% |
| Drug Interaction |
3.0% |
| Drug Toxicity |
3.0% |
| Multi-organ Failure |
3.0% |
| Nasal Congestion |
3.0% |
| Oedema Peripheral |
3.0% |
|
| Concomitant |
| Pulmonary Arterial Hypertension |
58.2% |
| Product Used For Unknown Indication |
20.0% |
| Pulmonary Hypertension |
8.1% |
| Drug Use For Unknown Indication |
2.4% |
| Hypertension |
1.6% |
| Cor Pulmonale Chronic |
1.2% |
| Diabetes Mellitus |
1.2% |
| Erectile Dysfunction |
1.1% |
| Chronic Obstructive Pulmonary Disease |
1.0% |
| Pain |
0.9% |
| Hypercholesterolaemia |
0.8% |
| Hepatitis C |
0.5% |
| Type 2 Diabetes Mellitus |
0.5% |
| Portopulmonary Hypertension |
0.4% |
| Prophylaxis |
0.4% |
| Gastrooesophageal Reflux Disease |
0.4% |
| Scleroderma |
0.4% |
| Hiv Infection |
0.3% |
| Oedema |
0.3% |
| Pulmonary Fibrosis |
0.3% |
|
| Death |
29.0% |
| Vomiting |
7.3% |
| Pneumonia |
7.2% |
| Syncope |
5.4% |
| Pulmonary Arterial Hypertension |
5.3% |
| Dyspnoea |
5.2% |
| Right Ventricular Failure |
4.1% |
| Pulmonary Hypertension |
3.7% |
| Respiratory Failure |
3.7% |
| Sepsis |
3.5% |
| Pulmonary Oedema |
3.3% |
| Pyrexia |
3.2% |
| Transfusion |
2.6% |
| Urinary Tract Infection |
2.6% |
| Lung Transplant |
2.5% |
| Oedema Peripheral |
2.4% |
| Weight Decreased |
2.4% |
| Weight Increased |
2.3% |
| Fall |
2.2% |
| Device Related Infection |
2.1% |
|
| Interacting |
| Hypertension |
28.0% |
| Pulmonary Arterial Hypertension |
24.0% |
| Erectile Dysfunction |
12.0% |
| Hiv Infection |
8.0% |
| Parkinson's Disease |
8.0% |
| Product Used For Unknown Indication |
8.0% |
| Depression |
4.0% |
| Migraine |
4.0% |
| Pulmonary Hypertension |
4.0% |
|
| C-reactive Protein Increased |
20.0% |
| Erectile Dysfunction |
10.0% |
| Hypotension |
10.0% |
| Iiird Nerve Paralysis |
10.0% |
| Parkinson's Disease |
10.0% |
| Petit Mal Epilepsy |
10.0% |
| Pneumonia |
10.0% |
| Po2 Decreased |
10.0% |
| Pulmonary Arterial Hypertension |
10.0% |
|
